Content about Company Earnings Announcement

MINNEAPOLIS — Target Corp. reported net sales of nearly $6 billion in January, the company said Thursday.

The mass merchandise retailer reported sales of $5.97 billion, a 29.6% increase over the $4.6 billion reported in January 2012. Comps for the period, which ended Saturday, increased 3.1%.

SAN FRANCISCO — McKesson Corporation on Thursday reported $31.2 billion in revenue for its third quarter ended Dec. 31, up 1%. 

“Our full year view of the operating performance in our Distribution Solutions segment is now better than our original expectations, and our full year view of the operating performance in the primary businesses in Technology Solution remains unchanged,” stated John Hammergren, chairman and CEO. 

INDIANAPOLIS — Eli Lilly and Company on Tuesday reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.

AMSTERDAM — Ahold reported sales of $10.4 billion for fourth quarter 2012 and $43.6 billion for the entire fiscal year, the company said in an earnings report.

That marked a 7.5% sales increase compared with fourth quarter 2011 and an 8.5% increase compared with fiscal year 2011, respectively.

MINNEAPOLIS — The sale of 877 stores to Cerberus Capital Management will help Supervalu re-energize its remaining three businesses, current Supervalu president and CEO Wayne Sales told analysts Thursday morning. "What this means … is the company is smaller," Sales said. "And we exit with a much smaller balance sheet to ensure liquidity going forward," he said. This sale will not be followed by any further divestitures, Sales said. "We're not shopping any other assets."

MEMPHIS, Tenn. — Fred's on Thursday reported a 1% sales decline to $209.9 million for the five-week fiscal month ended Dec. 29. Comparable store sales for the month decreased 4.2% compared with a decline of 0.4% in the same period last year.

PITTSBURGH — The Food and Drug Administration has approved a generic hypertension drug made by Mylan, the company said.

Mylan announced the approval and launch of candesartan cilexetil and hydrochlorothiazide tablets in the 16/12.5-mg, 32/12.5-mg and 32/25-mg strengths. Mylan said it was the first company to submit a complete regulatory approval application for the drug and is thus entitled to 180 days of market exclusivity in which to compete directly with the branded version.

SLOUGH, England — The battle for Schiff Nutrition is on. Reckitt Benckiser on Friday commenced its previously announced tender offer to acquire all of the outstanding shares of Schiff Nutrition — a provider of branded vitamins, nutrition supplements and nutrition bars in the United States and elsewhere — for $42 per share in cash, or approximately $1.4 billion.

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported revenue dropped 0.6% to $79.5 billion for its fiscal 2012 ended Sept. 30. Diluted earnings per share were a record $2.76, up 10% over the prior fiscal year diluted earnings per share from continuing operations. Gross profit was up 6.7% to $2.7 billion.

MORRISTOWN, N.J. — Bayer HealthCare on Tuesday signed a merger agreement to acquire Schiff Nutrition International, and with that, prominent supplement brands Digestive Advantage, MegaRed, Move Free and Airborne. These four products accounted for 70% of all Schiff sales, noted Marijn Dekkers, Bayer CEO, during an analyst call Wednesday morning. "This acquisition will strengthen Bayer's leading OTC business and complement our existing nutritionals business with well-established strong brands," he said. 

SUNBURY, Pa. — Weis Markets on Friday reported third-quarter net income of $17.2 million, up 1.2% for the period ended Sept. 29, while its earnings per share increased 1.6% to $0.64 per share compared to the same period in 2011.

CINCINNATI — Procter & Gamble announced on Thursday a decrease in both first-quarter net sales and diluted earnings per share from continuing operations, as core earnings per share rose 5%.

For the July-September period, net sales totaled $20.7 billion, a decrease of 4% compared with the year-ago period — including a negative 6% impact from foreign exchange.